Skip to main content
. 2020 Aug 20;38(41):6352–6356. doi: 10.1016/j.vaccine.2020.08.045

Table 2.

HLA binding affinity of similar 9-amino acids sequences between SARS-CoV-2 and Mycobacterium bovis predicted by NetMHCpan 4.1.

Predicted HLA binding affinity
Predicted HLA binding affinity
Amino acid sequence SARS-CoV-2 BCG Gene name in SARS-CoV-2 Protein name in BCG HLA allele SARS-CoV-2 BCG HLA allele SARS-CoV-2 BCG
Sequence 1 VLGSLAATV VLGGLAATV ORF1ab (nsp9) UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase HLA-A*02:01 0.36 (High) 0.32 (High) Not predicted
Sequence 2 LQGPPGTGK LLGPPGTGK ORF1ab (nsp13) Type VII secretion AAA-ATPase EccA HLA-A*03:01 0.42 (High) 0.03 (High) HLA-A*11:01 0.47 (High) 0.50 (High)
Sequence 3 QPTSEAVEA RPTSEAVEA ORF1ab (nsp2) PPOX class F420-dependent enzyme HLA-B*07:02 1.89 (Weak) 0.65 (Weak) Not predicted
Sequence 4 LAPLLSAGI LAPLLCAGI ORF1ab (nsp3) Alcohol dehydrogenase HLA-C*01:02 0.36 (High) 1.6 (Weak) Not predicted
Sequence 5 LAPLLSAGI LAPLLSAGA ORF1ab (nsp3) Metal-transporting ATPase Not predicted Not predicted
Sequence 6 LVPFWITIA LGPFWITIA ORF1ab (nsp4) Sugar ABC transporter permease Not predicted Not predicted

Different amino acid residues between SARS-CoV-2 and Mycobacterium bovis are underlined. Common HLA-A (A*01:01, A*02:01, A*03:01, A*11:01, A*24:02, A*33:03), HLA-B (B*07:02, B*08:01, B*44:03, B*52:01) and HLA-C (C*01:02, C*03:04, C*05:01, C*06:02, C*07:01) were tested for peptide binding affinity. The amino acid sequences of both SARS-CoV-2 and Mycobacterium bovis were analyzed by a computer algorithm (NetMHCpan 4.1, http://www.cbs.dtu.dk/services/NetMHCpan/). High indicates strong binding peptides. Weak indicates weak binding peptides. Not predicted indicates that these is no HLA allele which can bind to peptide sequences among tested HLA alleles. Frequency of HLA alleles among humans were searched by a publicly available database (Allele Frequency Net Database, http://www.allelefrequencies.net/hla.asp).